Is Betamethasone + Clioquinol registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 2 valid registrations of Betamethasone + Clioquinol, including BETNOVATE-C CREAM (3,0.1 % (W/W),% (W/W), Cream, SAR 13.10); BETNOVATE-C OINT. (3,0.1 % (W/W),% (W/W), Ointment, SAR 13.10).

Active substances

Betamethasone + Clioquinol

SFDA 2
NHS prices 1

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
BETNOVATE-C CREAM	3,0.1 % (W/W),% (W/W)	Cream · Topical	1 Tube	SAR 13.10	NCE · Prescription	GLAXO SAUDI ARABIA	Valid
BETNOVATE-C OINT.	3,0.1 % (W/W),% (W/W)	Ointment · Topical	1 Tube	SAR 13.10	NCE · Prescription	GLAXO SAUDI ARABIA	Valid

Indications — CHI Daman Drug Formulary

ECZEMA

Prices — United States and England

Source	Product as listed	Price	Unit / pack	Date
NHS Drug Tariff	Betamethasone valerate 0.1% / Clioquinol 3% cream	£100.43	30 gram	1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.